Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients.

@article{Friedman2008ScreeningSF,
  title={Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients.},
  author={GaryD. Friedman and Elizabeth Dawn Flick and Natalia V. Udaltsova and James I-Chih Chan and CharlesP. Quesenberry and Laurel A. Habel},
  journal={Pharmacoepidemiology and drug safety},
  year={2008},
  volume={17 1},
  pages={
          27-36
        }
}
PURPOSE Determine the risk of cancer in statin users. METHODS Risk of cancer in up to 9.4 years after first recorded receipt of statins was evaluated in subscribers of an integrated health care program in northern California. Statin use and cancer development were ascertained from the program's pharmacy records and cancer registry from August 1994 to December 2003. RESULTS Most of the 361,859 statin users received lovastatin, simvastatin or both. Results are presented from analyses with 2… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 103 CITATIONS, ESTIMATED 59% COVERAGE

179 Citations

0102030'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 179 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…